Abiopharma

🔍 Zapolsky David (Executive)

Company: AMAZON COM INC (AMZN)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Acquired 9,900 shares of Common Stock, par value $.01 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 51,090.00 | transaction_form_type: 4
• Acquired 5,530 shares of Common Stock, par value $.01 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 56,620.00 | transaction_form_type: 4
• Sold 1,138 shares of Common Stock, par value $.01 per share at $257.7019 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 55,482.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,782 shares of Common Stock, par value $.01 per share at $258.6357 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 53,700.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 2,133 shares of Common Stock, par value $.01 per share at $259.6335 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 51,567.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 1,119 shares of Common Stock, par value $.01 per share at $260.449 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 50,448.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 9,258 shares of Common Stock, par value $.01 per share at $259.77 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 41,190.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 9,900 shares of Restricted Stock Unit Award (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2028-02-21 | Exercise: 2023-05-21 | equity_swap_involved: 0 | shares_owned_after: 50,300.00 | transaction_form_type: 4 | Footnotes: F6, F7
• Sold 5,530 shares of Restricted Stock Unit Award (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2030-02-21 | Exercise: 2025-05-21 | equity_swap_involved: 0 | shares_owned_after: 108,406.00 | transaction_form_type: 4 | Footnotes: F6, F8

Footnotes:

• F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/03/2025.
• F2: Represents the weighted average sale price. The highest price at which shares were sold was $258.23 and the lowest price at which shares were sold was $257.24.
• F3: Represents the weighted average sale price. The highest price at which shares were sold was $259.23 and the lowest price at which shares were sold was $258.25.
• F4: Represents the weighted average sale price. The highest price at which shares were sold was $260.19 and the lowest price at which shares were sold was $259.25.
• F5: Represents the weighted average sale price. The highest price at which shares were sold was $261.00 and the lowest price at which shares were sold was $260.26.
• F6: Converts into Common Stock on a one-for-one basis.
• F7: This award vests based upon the following vesting schedule: 2,260 shares on May 21, 2023; 2,240 shares on each of August 21, 2023, November 21, 2023, and February 21, 2024; 3,240 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 3,940 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 3,920 shares on February 21, 2026; 9,920 shares on May 21, 2026; 9,900 shares on each of August 21, 2026, November 21, 2026, and February 21, 2027; 7,640 shares on May 21, 2027; and 7,620 shares on each of August 21, 2027, November 21, 2027, and February 21, 2028.
• F8: This award vests based upon the following vesting schedule: 5,050 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 5,049 shares on February 21, 2026; 5,530 shares on each of May 21, 2026, August 21, 2026, and November 21, 2026; 5,529 shares on February 21, 2027; 5,797 shares on each of May 21, 2027 and August 21, 2027; 5,796 shares on each of November 21, 2027 and February 21, 2028; 10,474 shares on each of May 21, 2028, August 21, 2028, and November 21, 2028; 10,473 shares on February 21, 2029; 8,067 shares on each of May 21, 2029 and August 21, 2029; and 8,066 shares on each of November 21, 2029 and February 21, 2030.
• REMARKS: The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.